Objective: To identify the type and pattern of gene mutation of a developmental delayed child and her family members via gene mutation analysis for the accurate diagnosis of disease in this patient. Methods: Peripheral blood DNA was extracted from the proband as well as her family members - father and mother, and gene mutation screening was performed by high throughput sequencing. The pathogenic candidate genes were identified according to the clinical phenotype data combined with the results of gene mutation screening. Sanger sequencing technology was used to validate the pathogenic mutation sites of proband and her family pedigree. Results: Heterozygous missense variants in MECP2 gene and PTPN11 gene were identified in proband by high throughput sequencing, which were c.398G> A, p.Arg133His and c.188A> G, p.Tyr63Cys, respectively. Sanger sequencing revealed that the MECP2 gene mutation leading to Rett syndrome in proband was inherited from her mother and the PTPN11 gene mutation leading to Noonan syndrome was from her father. The two missense variations detected were pathogenic variants in concordance with the clinical phenotype of the proband, her mother and father, respectively. Conclusions: In this study, two pathogenetic variants are identified in the developmental delayed child by high-throughput sequencing, leading to the occurrence of two different hereditary syndrome in the same patient. It is suggested that two or more phenotypes of disease may be present in the same patient, and attention should be paid to this posibility.
LU Jing, XU Yufei, QING Yanrong, HAN Cong, LI Niu, YU Tingting, YAO Ruen, WANG Jian
. Concurrent gene mutation analysis of a developmental delayed child with Rett syndrome and Noonan syndrome[J]. Journal of Diagnostics Concepts & Practice, 2018
, 17(02)
: 147
-150
.
DOI: 10.16150/j.1671-2870.2018.02.005
[1] 傅启华, 王剑. 下一代测序技术在罕见病分子诊断中的应用[J]. 中华检验医学杂志, 2015,38(1):4-6.
[2] Hu X, Li N, Xu Y, et al.Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience[J]. Genet Med,2017,195.
[3] Yang Y, Muzny DM, Xia F, et al.Molecular findings among patients referred for clinical whole-exome sequen-cing[J]. JAMA,2014,312(18):1870-1879.
[4] Retterer K, Juusola J, Cho MT, et al.Clinical application of whole-exome sequencing across clinical indications[J]. Genet Med,2016,18(7):696-704.
[5] Evans BJ.Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing[J]. Genet Med,2013,15(12):915-920.
[6] Armstrong J, Aibar E, Pineda M, et al.Prenatal diagnosis in Rett syndrome[J]. Fetal Diagn Ther,2002,17(4):200-204.
[7] Neul JL, Kaufmann WE, Glaze DG, et al.Rett syndrome: revised diagnostic criteria and nomenclature[J]. Ann Neurol,2010,68(6):944-950.
[8] Cole RB.Noonan's syndrome: a historical perspective[J]. Pediatrics,1980,66(3):468-469.
[9] Romano AA, Allanson JE, Dahlgren J, et al.Noonan syndrome: clinical features, diagnosis, and management guidelines[J]. Pediatrics,2010,126(4):746-759.
[10] Xu S, Fan Y, Sun Y, et al.Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders[J]. BMC Med Genomics,2017,10(1):62.
[11] Posey JE, Harel T, Liu P, et al.Resolution of disease phenotypes resulting from multilocus genomic variation[J]. N Engl J Med,2017,376(1):21-31.
[12] Bougeard G, Baert-Desurmont S, Tournier I, et al.Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome[J]. J Med Genet,2006,43(6):531-533.
[13] Shimojima K, Ondo Y, Matsufuji M, et al.Concurrent occurrence of an inherited 16p13.11 microduplication and a de novo 19p13.3 microdeletion involving MAP2K2 in a patient with developmental delay, distinctive facial features, and lambdoid synostosis[J]. J Med Genet,2016,59(11):559-563.
